HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
50 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CCR2
C-C motif chemokine receptor 2
Chromosome 3 Β· 3p21.31
NCBI Gene: 729230Ensembl: ENSG00000121807.8HGNC: HGNC:1603UniProt: P41597
553PubMed Papers
21Diseases
10Drugs
5Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneReceptor
RESEARCH IMPACT
Highly Studied
CLINICAL
Clinical TrialsOMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of monocyte chemotaxischemokine-mediated signaling pathwayplasma membranecytoplasmcystic disease of lungHIV-1 infectionCOVID-19celiac disease
✦AI Summary

CCR2 (C-C motif chemokine receptor 2) is a chemokine receptor that plays a critical role in inflammatory cell recruitment and tissue homeostasis. The primary function of CCR2 is to mediate monocyte/macrophage trafficking through binding to its ligands, particularly CCL2 1. CCR2 is expressed on inflammatory monocyte subsets (CX3CR1lo CCR2+ Gr1+) that are actively recruited to inflamed tissues, distinguishing them from tissue-resident macrophage populations 12. The CCL2-CCR2 axis mediates multiple pathological processes including cardiovascular disease, where CCR2+ macrophages contribute to pulmonary hypertension through crosstalk with smooth muscle cells 3 and atherosclerosis development 4. In cancer, CCR2 signaling promotes tumor progression by recruiting immunosuppressive macrophages and facilitating metastasis 56. CCR2 is also essential for joint inflammation in osteoarthritis, where CCL2/CCR2-mediated monocyte recruitment drives cartilage destruction 7. The receptor's significance extends to clinical applications, as CCR2+ macrophage abundance correlates with cardiac dysfunction in heart failure patients 2, and CCL2 expression serves as a prognostic marker in hepatocellular carcinoma 6. Therapeutically, dual CCR2/CCR5 targeting shows promise for treating multiple inflammatory diseases 3.

Sources cited
1
CCR2 is expressed on inflammatory monocyte subsets that are actively recruited to inflamed tissues
PMID: 12871640
2
CCR2+ macrophages are maintained through monocyte recruitment and correlate with cardiac dysfunction in heart failure
PMID: 29892064
3
CCR2 mediates macrophage-smooth muscle cell crosstalk in pulmonary hypertension
PMID: 31320454
4
CCL2-CCR2 axis orchestrates inflammatory monocyte trafficking in atherosclerosis
PMID: 35567558
5
CCR2 signaling promotes cancer progression by recruiting immunosuppressive macrophages
PMID: 38643840
6
CCL2 expression serves as prognostic marker in hepatocellular carcinoma and CCR2 blockade inhibits tumor growth
PMID: 26452628
7
CCL2/CCR2 mediates monocyte recruitment and cartilage destruction in osteoarthritis
PMID: 27965260
Disease Associationsβ“˜21
cystic disease of lungOpen Targets
0.62Moderate
HIV-1 infectionOpen Targets
0.40Weak
COVID-19Open Targets
0.37Weak
celiac diseaseOpen Targets
0.35Weak
rheumatoid arthritisOpen Targets
0.27Weak
alcohol drinkingOpen Targets
0.23Weak
Oral ulcerOpen Targets
0.19Weak
non-alcoholic steatohepatitisOpen Targets
0.16Weak
neoplasmOpen Targets
0.14Weak
mouth diseaseOpen Targets
0.13Weak
diabetic nephropathyOpen Targets
0.12Weak
infectionOpen Targets
0.11Weak
cancerOpen Targets
0.11Weak
ulcerative colitisOpen Targets
0.11Weak
hepatocellular carcinomaOpen Targets
0.11Weak
chronic obstructive pulmonary diseaseOpen Targets
0.11Weak
breast cancerOpen Targets
0.11Weak
experimental autoimmune encephalomyelitisOpen Targets
0.11Weak
multiple sclerosisOpen Targets
0.11Weak
achalasia-alacrima syndromeOpen Targets
0.10Weak
Polycystic lung diseaseUniProt
Pathogenic Variants5
NM_001123396.4(CCR2):c.641_646del (p.Pro214_Leu215del)Pathogenic
Cystic disease of lung
β˜†β˜†β˜†β˜†2024β†’ Residue 214
NM_001123396.4(CCR2):c.182T>G (p.Met61Arg)Pathogenic
Cystic disease of lung
β˜†β˜†β˜†β˜†2024β†’ Residue 61
NM_001123396.4(CCR2):c.887C>A (p.Thr296Asn)Pathogenic
Cystic disease of lung
β˜†β˜†β˜†β˜†2024β†’ Residue 296
NM_001123396.4(CCR2):c.59_60insAC (p.Thr21fs)Pathogenic
Cystic disease of lung
β˜†β˜†β˜†β˜†2024β†’ Residue 21
NM_001123396.4(CCR2):c.356T>G (p.Leu119Arg)Pathogenic
Cystic disease of lung
β˜†β˜†β˜†β˜†2024β†’ Residue 119
View on ClinVar β†—
Drug Targets10
AZD2423Phase II
C-C chemokine receptor type 2 antagonist
chronic obstructive pulmonary disease
BMS-741672Phase II
C-C chemokine receptor type 2 antagonist
neuropathic pain
BMS-813160Phase II
C-C chemokine receptor type 2 antagonist
diabetic nephropathy
CENICRIVIROCPhase III
C-C chemokine receptor type 2 antagonist
non-alcoholic steatohepatitis
ILACIRNONPhase II
C-C chemokine receptor type 2 antagonist
diabetic nephropathy
JNJ-41443532Phase II
C-C chemokine receptor type 2 antagonist
type 2 diabetes mellitus
MK-0812Phase II
C-C chemokine receptor type 2 antagonist
multiple sclerosis
PF-04634817Phase II
C-C chemokine receptor type 2 antagonist
diabetic nephropathy
PF-4136309Phase II
C-C chemokine receptor type 2 antagonist
hepatitis C virus infection
PLOZALIZUMABPhase II
C-C chemokine receptor type 2 inhibitor
metastatic malignant neoplasm
Related Genes
CSF1Protein interaction100%CXCL8Protein interaction100%CCL3L1Protein interaction100%CCL8Protein interaction100%CCL13Protein interaction100%CCL15Protein interaction100%
Tissue Expression6 tissues
Lung
100%
Bone Marrow
54%
Heart
36%
Liver
21%
Ovary
6%
Brain
5%
Gene Interaction Network
Click a node to explore
CCR2CSF1CXCL8CCL3L1CCL8CCL13CCL15
PROTEIN STRUCTURE
Preparing viewer…
PDB7P8X Β· 1.40 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.82LoF Tolerant
pLIβ“˜
0.05Tolerant
Observed/Expected LoF0.92 [0.40–1.82]
RankingsWhere CCR2 stands among ~20K protein-coding genes
  • #441of 20,598
    Most Researched553 Β· top 5%
  • #3,462of 5,498
    Most Pathogenic Variants5
  • #16,690of 17,882
    Most Constrained (LOEUF)1.82
Genes detectedCCR2
Sources retrieved50 papers
Response timeβ€”
πŸ“„ Sources
50β–Ό
1
CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
PMID: 31320454
Eur Respir J Β· 2019
1.00
2
The human heart contains distinct macrophage subsets with divergent origins and functions.
PMID: 29892064
Nat Med Β· 2018
0.90
3
Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2.
PMID: 35404389
J Exp Med Β· 2022
0.80
4
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications.
PMID: 36110847
Front Immunol Β· 2022
0.80
5
The novel potential therapeutic target PSMP/MSMP promotes acute kidney injury via CCR2.
PMID: 38796708
Mol Ther Β· 2024
0.78